A series of eight double and triple mutants of mouse acetylcholinesterase (AChE; EC 3.1.1.7), with substitutions corresponding to residues found largely within the butyrylcholinesterase (BChE; EC 3.1.1.8) active-centre gorge, was analysed to compare steady-state kinetic constants for substrate turnover and inhibition parameters for enantiomeric methylphosphonate esters. The mutations combined substitutions in the acyl pocket (Phe 295 →Leu and Phe 297 → Ile) with the choline-binding site (Tyr 337 → Ala and Phe 338 → Ala) and with a side chain (Glu 202 → Gln) N-terminal to the active-site serine, Ser 203 . The mutations affected catalysis by increasing K m and decreasing k cat , but these constants were typically affected by an order of magnitude or less, a relatively small change compared with the catalytic potential of AChE. To analyse the constraints on stereoselective phosphonylation, the mutant enzymes were reacted with a congeneric series of S P -and R P -methylphosphonates of known absolute stereochemistry. Where possible, the overall reaction rates were deconstructed into the primary constants for formation of the reversible complex and intrinsic phosphonylation. The multiple mutations greatly reduced the reaction rates of the more reactive S P -methylphosphonates, whereas the rates of reaction with the R P -methylphosphonates were markedly enhanced. With the phosphonates of larger steric bulk, the enhancement of rates for the R P enantiomers, coupled with the reduction of the S P enantiomers, was sufficient to invert markedly the enantiomeric preference. The sequence of mutations to enlarge the size of the AChE active-centre gorge, resembling in part the more spacious gorge of BChE, did not show an ordered conversion into BChE reactivity as anticipated for a rigid template. Rather, the individual aromatic residues may mutually interact to confer a distinctive stereospecificity pattern towards organophosphates.
INTRODUCTION
Acetylcholinesterase (AChE; EC 3.1.1.7) and butyrylcholinesterase (BChE; EC 3.1.1.8) are serine hydrolases that structurally belong to the class of proteins known as the esterase/lipase family within the α/β-hydrolase-fold superfamily [1] . AChE and BChE display substantial similarity in their structures, yet differ in substrate specificities and sensitivities to a wide range of inhibitors [2] [3] [4] . The available three-dimensional structures of AChE coupled with kinetic studies of the AChE mutants with substrates and inhibitors delineate domains within the active site [3, 5, 6] 295 and Phe 297 (throughout the present paper, numbers refer to the numbering of amino acid residues in mouse AChE). In BChE, which, unlike AChE, can efficiently catalyse hydrolysis of larger molecules such as butyrylcholine and benzoylcholine, modified substrate selectivity was shown to result mainly from differences in the acyl-pocket structure between the two enzymes [3, 5, 7] . Aliphatic residues of smaller dimensions are found at positions corresponding to Leu 295 and Ile 297 in BChE allowing larger substrates to fit into the active site in an orientation appropriate for efficient catalysis [1, 8] . Cholinesterases also catalyse phosphonylation of the catalytic serine by organophosphonates. However, unlike carboxyl ester substrates, the phosphonylated enzyme reacts slowly with water, rendering long-lasting conjugation and inhibition of the enzyme. Furthermore, the AChE reaction with organophosphates displays marked stereoselectivity that can also be utilized for investigation of the steric interactions with structural elements of the active centre [9] [10] [11] [12] . The tetrahedral organophosphates contain substituents on the phosphorus atom with ideal bond angles of 109
•
. Therefore their substituent groups will project differently in the active site from those in planar substrates with trigonal, ideally 120
• , bond angles. In the case of the organophosphateAChE interaction the three-point attachment comes from (i) a conjugating bond distance between the active site serine and the phosphonyl phosphorus, (ii) entry of the phosphonyl oxygen into the oxyanion hole, and (iii) the thiocholine leaving group directed towards the gorge exit [13] .
Because the cholinesterases contain the inherent power of stereoselectivity, and because their interaction with organophosphates enables one to deconstruct steady-state catalysis, in order to examine the transesterification step directly, we have examined the influence of multiple site-directed mutations in AChE on substrate turnover and active-centre serine phosphonylation. Mutants were subjected to phosphonylation by a series of enantiomeric pairs, S P and R P , of alkyl methylphosphonates in which the structure of the alkoxy group was varied: isopropyl, 3,3-dimethylbutyl and cycloheptyl methylphosphonyl thiocholine (iPrMPTCh, DMBMPTCh and CHMPTCh respectively; Figure 1 ). Double and triple mutants of mouse AChE with residue substitutions at selected positions in the active-centre gorge ( Figure 2 ) were prepared to correlate, through structural perturbations, the functional architecture of the AChE gorge with the reactivity and stereoselectivity of the chiral phosphonates. Catalytic constants for acetylthiocholine iodide (ATCh) hydrolysis and rates of phosphonylation of mutant enzymes were evaluated with respect to the structure and steric orientation of the substrate and selected amino acid residues within the active-centre gorge of the enzyme. Multiple mutants of AChE containing F295L (Phe 295 → Leu), F297I and Y337A have enabled us to dissect the structural basis for the divergence between AChE and BChE inhibitor specificity and kinetics.
MATERIALS AND METHODS

Chemicals
S P -and R P -alkyl methylphosphonyl thiocholines ( Figure 1 ) were synthesized and isolated as resolved S P and R P enantiomers [9] . Stock solutions in acetonitrile were kept at − 20
• C, and aliquots were diluted in water immediately before use. MEPQ [7- 
Production and purification of AChE
Preparation of the cDNA that encodes mouse AChE truncated at position 548, which yields a monomeric form of the enzyme, has been described previously in [14] and was used in mutagenesis as the template wild-type cDNA. Mutant mouse AChE cDNAs were generated by PCR-mediated standard mutagenesis procedures (QuikChange R Kit; Stratagene, San Diego, CA, U.S.A.). Multiple mutants were generated by combined subcloning of DNA fragments containing single mutations, or by performing mutagenesis using mutant DNA templates. Finally, cassettes of mutant constructs were subcloned into the mammalian expression vector, pCDNA3 (Invitrogen, San Diego, CA, U.S.A.). The nucleotide sequences of the cassettes were confirmed by doublestranded sequencing.
Transfection of HEK-293 cells (purchased from American Type Culture Collection, Atlanta, GA, U.S.A.), as well as selection of expressing cells by aminoglycoside resistance conferred by co-transfection of a neomycin acetyltransferase gene, were described previously in [10] . Stable transfectants were grown to confluence in either 10-cm-diameter dishes or threetiered flasks with a cell growth surface area of 500 cm 2 (Nalge Nunc International, Rochester, NY, U.S.A.) before replacement of the foetal-bovine-serum-supplemented Dulbecco's modified Eagle's medium with serum-free medium, Ultraculture cell culture medium (BioWhittaker, Walkersville, MD, U.S.A.). Harvests of the medium containing the soluble monomeric form of AChE were performed at 2-3 day intervals; by replacement of medium on the cell monolayers, cultures could be continued for several weeks.
Several litres of media were subjected to affinity chromatography to purify the mutant enzymes, typically in amounts of 2-10 mg. Procainamide affinity resin utilized CNBr-activated Sepharose CL-4B resin with a hexanoic alkyl chain [15] . Harvested ultraculture medium containing the expressed enzyme was centrifuged (2000 g for 15 min at 4
• C), and was assayed for AChE activity. MgCl 2 was added to a final concentration of 40 mM, then the resin suspension (1 ml for each 2 mg of AChE) and the mixture were allowed to stir in a spinner flask (Bellco, Wineland, NJ, U.S.A.) overnight at 4
• C in the presence of 0.02 % (w/v) NaN 3 . The medium was poured into a Bio-Rad Econo-column (Bio-Rad, Hercules, CA, U.S.A.), was allowed to pack by sedimentation, and then washed with equilibrating buffer [at 50-100 times the bed volume; 10 mM NaHCO 3 , 100 mM NaCl, 40 mM MgCl 2 and 0.02 % (w/v) NaN 3 , pH 8]. The enzyme was subsequently eluted by competition with 100 mM decamethonium bromide, at a low flow rate (1-1.5 ml · h −1 ). The purified enzyme was dialysed using the 14-16 kDa cutoff dialysis tubing (Spectrapore, Houston, TX, U.S.A.) against 4 litres of dialysis buffer [10 mM Tris/HCl, 100 mM NaCl, 40 mM MgCl 2 and 0.02 % (w/v) NaN 3 , pH 8.0] four times for 6 h. Pools of purified enzyme were stored at 4
• C.
AChE activity measurements
Enzyme activities were determined at 22
• C by the Ellman method using ATCh as substrate [16] . Reactions were started by adding substrate to 100 mM phosphate buffer, pH 7.0, containing 0.01 % (v/v) BSA, 0.33 mM DTNB and enzyme. The linear increase of absorbance was monitored from 15 s to 2 min against a blank containing buffer, BSA and DTNB. Maximum concentrations of ATCh did not exceed 100 mM. Whenever ATCh concentrations were greater than 1.0 mM, enzyme activity was corrected for spontaneous non-enzymic substrate hydrolysis.
Known concentrations of MEPQ or DEPQ were utilized to titrate the number of active sites, according to procedures described previously in [17, 18] .
AChE inhibition by organophosphates
In the inhibition experiments, enzyme samples were incubated for > 30 min with organophosphonates [in 100 mM phosphate buffer, pH 7.0, containing 0.01 % (v/v) BSA] in the absence of substrate; typically, three to five inhibitor concentrations were used. The inhibition reaction was stopped by the addition of ATCh (1.0 mM final concentration), and the extent of inhibition was determined by measuring the residual activity. To obtain the enzymic activity at time-zero inhibition, the enzyme was added to the reaction medium containing inhibitor and substrate. The image is based on computational analysis of the organophosphate binding in the AChE active centre described previously by Hosea et al. [21] . 
Kinetic equations
The evaluation of catalytic parameters was based on Scheme 1 (compare with [19] ). According to this scheme, the enzyme (E) associates reversibly with substrate (S) forming two binary complexes: the ES complex in the active site and the SE complex in a secondary peripheral site. The complex ES results in substrate hydrolysis with the rate constant k cat , whereas the SE complex is inactive. The ternary complex SES leads to substrate hydrolysis with a rate constant b k cat . Scheme 1 assumes that S has equal affinity for the active site of E and SE as does S for a peripheral site of E and ES. Constants K s and K ss are the respective ES and SE dissociation constants. The K s constant approximates to the Michaelis constant K m . Throughout the present paper the symbol K m will therefore be used instead of K s . Eqn (1) describes catalysis in Scheme 1:
where ν 0 is the initial steady-state rate of ATCh hydrolysis and e 0 is the total enzyme active-site concentration. The catalytic parameters were calculated by fitting experimental data to eqn (1) [3, 19] .
Scheme 1 Reaction scheme for substrate hydrolysis by acetylcholinesterase
Modified from [19] .
Scheme 2 Progressive inhibition of acetylcholinesterase by organophosphates
Modified from [20] .
Progressive inhibition of AChE by organophosphates is defined by Scheme 2 (cf. [20]). Enzyme (E) and organophosphate (OP) form a reversible Michaelis-type complex ([E][OP]
) from where the covalently phosphorylated enzyme (EP) and the leaving group of the organophosphate arise; k +2 is the first-order inhibition rate constant and k i is the overall second-order rate constant of inhibition. Scheme 2 is defined by eqn (2):
where ν 0 and ν i stand for the enzyme activity in the absence and in the presence of inhibitor (OP) respectively at the time of inhibition (t). K i approximates to the dissociation constant of the [E] [OP] complex, and k obs is the first-order rate constant of inhibition determined at any given inhibitor concentration. The k +2 and K i constants were calculated from eqn (2). When [OP] K i , constants k +2 and K i cannot be separately evaluated, because eqn (2) reduces to eqn (3):
from which k i was calculated. The k i constant corresponds to the ratio k +2 /K i .
RESULTS AND DISCUSSION
Effect of mutations on catalytic constants of ATCh hydrolysis
All multiple AChE mutants contain mutations inside the activecentre gorge of mouse AChE, and many resemble the residue replacements in the mouse BChE active site (F295L, F297I and Y337A). The activity of the enzymes for ATCh is shown in Figure 3 . The bell-shaped pS-curve of wild-type AChE activity reached an optimum at about 1 mM ATCh. Only the mutants, F295L/Y337A and F295L/Y337A/F338A, exhibited bell-shaped pS-curves similar to that of wild-type AChE, but reached a maximum at higher ATCh concentrations, whereas pS-curves of the other mutants resembled that of BChE [21] [22] [23] . All mutations studied revealed an increase of K m and a decrease of k cat compared with AChE (Table 1) . Two mutants, F295L/Y337A and Y337A/F338A, had a k cat similar to that of BChE. As a result of both a higher K m and lower k cat , the efficiency of catalysis (k cat /K m ) of the mutants at low substrate concentrations is less than that of wild-type AChE. Alanine at positions 295 and 297 resulted in a reduction of k cat , and compared with the corresponding mutants F295L/Y337A and F295L/F297I/Y337A, alanine substitution led to a further reduction in catalytic constants (cf. Table 1 ). In contrast, the single mutants, F295A and F297A, showed greater catalytic rates than the F295L and F297I mutants [10] . This combinatorial behaviour might be a consequence of altered structural integrity of the acyl pocket in the mutant enzyme. Replacement of the large phenylalanine residue with alanine can be expected to yield a void area, which should be occupied with water or result in collapse of the α-carbon chain.
For the F295L and F297I substitutions, the volume reduction and structural perturbation is smaller and less impacted by the concomitant Y337A substitution on the opposite face of the gorge. The aromatic residues F295, F297 and Y337 may serve to stabilize and orient ATCh for efficient catalysis. It should be noted that no natural cholinesterase identified at the present time contains alanine at positions corresponding to 295 and 297 in mouse AChE [1, 24] . Inhibition by excess substrate, resulting in bell-shaped pScurves, is explained by the binding of a substrate molecule to the peripheral site of the enzyme [19, 25] . Residues in the acyl pocket and choline-binding site do influence K ss and b values, demonstrating that these residues are linked to the catalytic influence of the binding of a second substrate molecule. The F295L substitution in the Y337A mutant shows a catalytic profile that resembles AChE in that this double mutant displays substrate inhibition (b < 1), whereas the F297I substitution in Y337A resembles BChE, where the double mutant shows apparent substrate activation (b > 1). The single mutants F295L and F297I show similar changes in the b parameter to those of the double mutant [3, 10] , showing that the Y337A substitution is not involved in the inhibition/activation process. Substitution F295L in the triple mutant F295L/Y337A/F338A also prevents the apparent substrate activation seen in Y337A/F338A (Figure 3 ). On the other hand, comparison of catalytic parameters of F295L/Y337A and E202Q/F295L/Y337A gives rise to the conclusion that the E202Q mutation is responsible for the apparent substrate activation (b > 1, cf. Table 1 ). Previous results showed that the single mutation E202Q of mouse AChE only slightly altered K m and k cat , but changed the K ss and b values [21] , and that the charge on Glu 202 probably has a role in stabilization of the transition state [26] [27] [28] .
Conformational changes of the acyl-pocket loop following conjugation of a large organophosphate and aging of the conjugate were reported in crystal-structure analysis of Torpedo californica AChE [29] . It is therefore reasonable to assume that mutations of phenylalanine residues to isoleucine, leucine or alanine could affect flexibility of the loop that encompasses peripheral site residues and may link the active site with the peripheral site. The concept of a functional linkage was first suggested by Changeux [30] to explain allosteric binding of certain inhibitors to AChE; later it was demonstrated directly with fluorescence spectra of ligands bound at the peripheral site or active centre [31, 32] .
Table 2 Constants (+ − S.E.M.) for inhibition of recombinant-DNA-derived mouse cholinesterases by chiral thiocholine methylphosphonates
The first-order inhibition constant (k +2 ) and enzyme-inhibitor equilibrium dissociation constant (K i ) were determined by non-linear regression of eqn (2) With the exception of F295L/Y337A/F338A, all other AChE mutants retained substantial catalytic capacity irrespective of whether their pS-profiles mimicked that of AChE or BChE.
Mutation analysis and phosphonylation of AChE
Mouse cholinesterases were phosphonylated by S P and R P enantiomers of CHMPTCh, iPrMPTCh or DMBMPTCh (Figure 1) . The phosphonate concentration was in excess of the enzyme concentration, and the inhibition followed first-order kinetics. The constants k +2 , K i and k i were evaluated from the dependence of k obs on the concentration of inhibitor [cf. eqns (2) and (3)]. Three different patterns for inhibition kinetics were obtained, as shown in Figures 4(A)-4(C) . For most reactions (32 out of 43) a linear dependence of k obs on the phosphonate concentration was obtained ( Figure 4A ), which did not allow the distinction of individual constants k +2 and K i . The same applies to the reactions (6 out of 43) presented in Figure 4 (B). The y-axis intercepts in Figures 4(B) and 4(C) are probably due to the formation of a reversible enzyme-inhibitor complex in which the inhibitor was not fully displaced by 1 mM ATCh that was used in the activity assay. This initial complex was not studied further. In Figure 4 (C), a non-linear dependence of k obs on the inhibitor concentration enabled us to calculate the primary constants for formation of the reversible complex (K i ) and the intrinsic phosphonylation constant (k +2 ) using eqn 2 ( Table 2 ). The k +2 values for R P compounds were typically less than one-half of k +2 for the S P compounds, whereas K i ranged between 12 and
Figure 4 Representative inhibition experiments of AChE mutants by alkyl methylphosphonyl thiocholines
From the analysis of inhibition at zero time (i.e. intercept on the y-axis), and from the relationship between k obs and inhibitor concentrations, inhibition kinetics displayed three different patterns: (A) all inhibition lines pass through log[Activity (%)] = 2.0, and k obs was linearly dependent on inhibitor concentration; (B) the y-intercept is below 100 % activity, whereas k obs and inhibitor concentration still show a linear relationship; (C) the inhibition lines also intercept the y-axes below 100 % activity, but k obs against inhibitor concentration deviates from linearity and approaches a limiting value at high inhibitor concentrations. This indicates that an appreciable concentration of enzyme-inhibitor complex is accumulating. 220 nM. A two orders of magnitude range of second-order rate constants (k i ) for the phosphonates is primarily due to variation in K i , the dissociation constant. Hence, K i appears to be the major determinant of AChE reactivity toward organophosphates [9, 20, 33] .
The high enantiomeric stereoselectivity of wild-type AChE with a preference for S P over R P enantiomers was decreased by mutations in the choline-binding site and acyl pocket (Tables 3-5) . Generally, the mutations reduced inhibition rates by S P enantiomers, whereas inhibition rates by R P enantiomers were enhanced. The most dramatic change in rates was obtained in the inhibition of F297I/Y337A by R P -CHMPTCh, where the rate was increased 160-fold compared with the k i of the wild-type AChE (cf . Table 3 ). Moreover, the mutant F297I/Y337A was inhibited 16-fold more rapidly by R P -than S P -CHMPTCh, showing inverted stereospecificity, greatly exceeding the ratio of rates for the single mutant F297I [10] . S P -and R P -DMBMPTCh showed the most rapid inhibition rates of the three enantiomeric phosphonate pairs, whereas the enantiomeric selectivity for this pair with wild-type AChE was the lowest of the three (Table 5) . Inhibition rates with both DMBMPTCh enantiomers for all other multiple mutants (except Y337A/F338A) slightly decreased compared with that of wildtype AChE. The 3,3-dimethylbutyl moiety, being a primary instead of a secondary alkoxy moiety, has additional degrees of torsional freedom over the cycloheptyl and isopropyl groups. The flexibility conferred from bond rotation, along with the hydrophobicity, may contribute to the greater reactivity of the R P -DMBMPTCh organophosphate over the other R Pmethylphosphonates. The flexibility of this group may also enhance the S P reaction through its fit in the choline subsite. Although the Y337A mutation had a small effect on the rate of phosphonylation, the rate for the Y337A/F338A mutant increased two-fold for all S P and R P enantiomers, except for S P -CHMPTCh, showing a stereoselectivity similar to, or slightly greater than, that of the wild-type AChE (Tables 3-5) . Enlargement of the cholinebinding site by mutations Y337A and F338A may provide a preferable orientation for organophosphate reactivity in the active centre.
Since the absolute stereochemistry of these phosphonates is known, molecular-dynamics analysis of energy-minimized conformations for S P -and R P -methylphosphonates in the active site of mouse AChE revealed the probable arrangement of substituent groups [21, 34] . In case of the S P enantiomer, the methylphosphonyl moiety can fit within the space constraints of the acyl pocket, the phosphonyl oxygen enters the oxyanion hole and the leaving group can fit into the space forming the choline subsite, close to the gorge exit (Figure 2 ). For the R P enantiomer, placement of the phosphonyl oxygen and the leaving group at these positions confronts a steric constraint of the alkoxy group in the acyl pocket. Alternatively, placement of the methyl group in the acyl pocket requires that either the phosphonyl oxygen is oriented out of the oxyanion hole or the leaving group is directed away from the gorge exit. By enlarging the acyl pocket so that the R P -alkoxy group orients in that direction, both positioning criteria for efficient phosphonylation can be satisfied and the rates are accelerated. Stabilization of the S P -methyl group within the confines of the acyl pocket by Phe 295 and Phe 297 ( Figure 2 ) is also critical for efficient reactivity, since rates of phosphonylation by the S P enantiomers are diminished for the acyl-pocket mutants, especially if Phe 297 is mutated. Furthermore, decreased reactivity of S P enantiomers, due to replacement of residues at either the acyl pocket or choline-binding site, is seen in the triple mutant F295L/F297I/Y337A.
Although the F295L/F297I/Y337A mutant resembles mouse BChE in composition of the acyl pocket and choline binding site, its reactivity toward S P enantiomers is approx. 20-fold lower than that for the mouse wild-type BChE (cf. Tables 3-5) . On the other hand, the reactivity of the triple mutant toward R P enantiomers approached that of BChE, except for R P -DMBMPTCh, which phosphonylated both AChE and BChE at slower rates. Thus comparison of k i constants for AChE and BChE with AChE mutants gives rise to the conclusion that the difference between AChE and BChE is not dictated solely by residues in the acyl pocket and the choline-binding site. Despite the 'equivalence' of residues in these regions of the two enzymes, their architectures are different. One difference not inherent in considerations of aromaticity and volume of the active centre is the flexibility of the α-carbon backbone surrounding the acyl pocket. For example, Arg 296 in AChE may be anchored by interactions with Pro 235 , Gln 369 and His 405 , imparting stability to the pocket, whereas in BChE, the residue at position 296 is serine. The smaller side chain and diminished interactions may be factors in conferring additional flexibility to the BChE acyl pocket. A recent study on a hexa-substituted mutant of human AChE that resembled residues of human BChE showed that this mutant did not mimic the reactivity of human BChE toward substrates and other covalent ligands, and it was suggested that the catalytically productive orientation of the catalytic triad histidine in BChE is maintained by a somewhat different array of interactions than that in AChE [35] .
General conclusions
The combinatorial approach to altering the dimensions of the active centre through mutation, when coupled with the greater discriminatory power of a congeneric series of enantiomeric methylphosphonates, reveals several characteristics of the AChE active centre. The overall dimensions of the acyl pocket are the critical determinant in maintaining stereoselectivity. Mutations enlarging the dimensions of the choline subsite, do not, in themselves, reduce stereoselectivity or reactivity. It is only when mutations in the choline subsite are combined with the acyl-pocket mutation at residue 297 that the most dramatic inversion in stereoselectivity is seen. Enhanced reactivity cannot be predicted simply on the basis of the enlarged volume of the gorge, since the favourable characteristics of elimination of steric occlusion may be offset by formation of non-productive complexes in the enlarged gorge. Enlarging the acyl pocket diminishes the reactivity of all of the S P -methylphosphonates, suggesting that positioning the methyl group within the confines of a small acyl pocket bordered by the two phenylalanine residues optimizes the position of the phosphorus for reaction in AChE. Simple partitioning of volume increases by side-chain removal does not give an ordered increase in reactivity of the R P compounds. 
